Three biotechnology companies sued Columbia University on Tuesday, alleging that the school has illegally extended the life of a lucrative patent for gene-splicing technology. Biogen Inc., Genzyme Corp., and Abbott Laboratories filed the lawsuit in U.S. District Court in Boston, claiming they have collectively paid tens of millions of dollars in royalties to Columbia for using the technology, and should not have to pay more.
July 17, 2003 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!
This event shines a spotlight on how individuals and firms are changing the investment advisory industry where it matters most.
Description: Fox Rothschild has an opening in the New York office for an attorney in our renowned Labor & Employment Department, working...
Our client, a large, privately-owned healthcare company, has engaged us to find an Assistant General Counsel for their headquarters located ...
A prestigious matrimonial law firm in Garden City is seeking a skilled Associate Attorney with 5 to 7 years of experience in family law. The...
